Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Recall raised to highest risk level by FDA. What to know
Sunscreen Recalled Nationwide as FDA Sets Risk Level
A voluntary recall was initiated by The W.S. Badger Company due to missing labels on a sunscreen product distributed nationwide.
This chocolate recall has been upgraded to FDA’s highest risk level
STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug Administration (FDA), which says consuming the product could “cause serious adverse health consequences or death.”
Lay’s recall increased to highest level, could cause ‘death’: FDA
The oversight could result in “death,” at least for those with a milk allergy or sensitivity, says the FDA. FDA initiated the recall on Dec. 13 and announced three days later that it was recalling the chips due to a potential or undeclared allergen. At present, no allergic reactions have been reported.
Axsome Therapeutics, FDA and migraine
US FDA approves Axsome Therapeutics' migraine drug
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
Axsome Therapeutics announces FDA approval of Symbravo
Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in
Axsome gets FDA approval for Symbravo for migraine
Axsome Therapeutics (NASDAQ:AXSM) has received FDA approval for its drug Symbravo for the acute treatment of migraine with or without aura in adults. Symbravo, a combination of meloxicam and rizatriptan,
type 2 diabetes, chronic kidney disease and FDA
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,
FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes
Doctors already use Ozempic to manage type 2 diabetes and reduce the risk of heart disease in patients with diabetes. This move, as reported by The Times, was based on research sh
US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),
1h
US FDA approves Vertex's non-opioid painkiller
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...
4h
Chocolate Recall Now Classified As Potentially Deadly, According To The FDA
Per the FDA, the recalled Cal Yee’s (or Cal Yee Farm branded) products were packaged in clear plastic zippered pouches in ...
1d
on MSN
Trump admin's FDA withdraws proposed federal rule to ban menthol cigarettes
Trump's FDA moved to squash a proposed rule to ban menthol cigarettes just one day after the president was sworn in, angering ...
3h
on MSN
US FDA identifies cybersecurity risks in certain patient monitors
The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with ...
WISH-TV
42m
FDA redefines ‘healthy’ food labels to help consumers make informed choices
The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...
2h
The Return of Snake Oil
The Trump administration is poised to supercharge America’s appetite for supplements.
Opinion
2h
Opinion
Do food warning labels actually work? Answering your questions.
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
Opinion
R Street Institute
2h
Opinion
Trump: Look at the Slow-Moving FDA
The Food and Drug Administration’s approval of low-risk tobacco pouches is welcome, but why did it delay for more than four ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Popular topics
# FDA
Related topics
Trump
Washington
United States
Food and Drug Administration
recall
Feedback